Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Continuous versus intermittent administration of piperacillin-tazobactam in intensive care unit patients with ventilator-associated pneumonia.

Fahimi F, Ghafari S, Jamaati H, Baniasadi S, Tabarsi P, Najafi A, Akhzarmehr A, Hashemian SM.

Indian J Crit Care Med. 2012 Jul;16(3):141-7. doi: 10.4103/0972-5229.102083.

PMID:
23188954
[PubMed]
Free PMC Article
2.

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review.

Mah GT, Mabasa VH, Chow I, Ensom MH.

Ann Pharmacother. 2012 Feb;46(2):265-75. doi: 10.1345/aph.1Q378. Epub 2012 Jan 24. Review.

PMID:
22274145
[PubMed - indexed for MEDLINE]
3.

The impact of ventilator-associated pneumonia on the Canadian health care system.

Muscedere JG, Martin CM, Heyland DK.

J Crit Care. 2008 Mar;23(1):5-10. doi: 10.1016/j.jcrc.2007.11.012. Review.

PMID:
18359415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk